Juno Pharmaceuticals

[CGPA @CdnGenerics]

On September 16-18, #Canada is hosting the International #Generic #Pharmaceutical Alliance (IGPA) Conference --> http://t.co/DoruZXVdQd.

[Pharmaceutical @Pharmaceutical]

Israeli Mini-Scanner Tells What's In Food, Drink Or Pills, Tel Aviv University Study: An Israeli start-up has ... http://t.co/St85IoYt2i

[Generic Pharmace @GenericPharmace]

'Generics to double in five years' - The Hindu http://t.co/z0yTijXLLQ

[AACR @AACR]

It's #OvarianCancerAwareness Month. There are 3 types of #ovca: http://t.co/Vus01oGQkr

[Generic Pharmace @GenericPharmace]

Another FTC Conduct Case to Bolster Generic Drug Competition: Pharmaceuticals ... - The National Law Review http://t.co/ZtQhg6Ns7b

[AACR @AACR]

Many cancers are preventable. You can take steps to reduce your risk: http://t.co/J9wsBR15C5

[Pharmaceutical News @PharmaIQ]

3 Major IT Trends will Shape #LifeSciences #PharmaIQ News http://t.co/1qwfDKTfmJ

[Pharmaceutical @Pharmaceutical]

Smart Phone Medicine: first uses of such an app was to monitor vital signs such as a runner's heart rate, by c... http://t.co/8XEdRDdS03

[PharmaTimes @PharmaTimes]

World's first 3D printed drug approved http://t.co/8N9lEDt8TQ #pharma #health

[CGPA @CdnGenerics]

New report highlights the importance of #generics and #biosimilars for future affordability of drug benefit plans. http://t.co/XzjmvEDKGr

[Juno Pharmaceuticals @PharmJuno]

WE ARE PLEASED TO ANNOUNCE THE LAUNCH OF OUR BRAND NEW WEBSITE! #genericpharmaceuticals http://t.co/IOCPbESEaj

[CGPA @CdnGenerics]

#Canada’s #healthcare system is under pressure from increasing costs and an aging population. Ease the pressure – choose #generic!

[Generic Pharmace @GenericPharmace]

Big Pharma's Pfizer And Merck To Feel Pinch Of Strong Dollar, Patent Loss - Forbes - Forbes http://t.co/XryzljrQip

[Generic Pharmace @GenericPharmace]

Two Inexpensive, Generic Drugs Prove Effective In Reducing Breast Cancer Death ... - Tech Times http://t.co/Estj55uJ4D

[The Associated Press @AP]

BREAKING: Israel's Teva Pharmaceutical to buy Allergan's generic pharmaceuticals business for $40.5 billion